Utilizing glycoengineering to construct cells is an efficient and flexible tool. Depending on the glycosylation pathway, CD BioGlyco provides various types of Glycoengineered Cell Constructs for clients. For example, GSL pathway-based glycan engineering cell construction.
Furthermore, we use a combination of gene editing approaches to eliminate and introduce the ability of cells to glycosylate de novo and develop sub-libraries of stably engineered homozygous cells. On the other hand, we classify glycosyltransferase genes into regulated and non-regulated based on transcriptomic data to further provide differentially regulated glycosylation steps and pathways.
Fig.1 GSL pathway-based glyco-engineered cell construction. (CD BioGlyco)
Technology: CRISPR–Cas9/CRISPRi tool
Journal: World Journal of Microbiology and Biotechnology
IF: 4.1
Published: 2020
Results: Innovative genome editing technologies based on CRISPR-Cas offer several features and advantages such as high efficiency and specificity as well as ease of handling, which facilitates the construction of cell factories. The CRISPR-Cas system is a three-step antiviral defense mechanism. First, Cas proteins can integrate short DNA spacer regions generated by invaders into CRISPR arrays in the host genome. Second, the CRISPR array consisting of the adapted spacer regions and repetitive sequences is transcribed into a long transcript called preCRISPR RNA (pre-crRNA). At the end of the processing, mature small CRISPR RNAs (crRNAs) are generated from the pre-crRNA and form a double strand with complementary reverse transcription activating RNAs (tracrRNAs). Third, a crRNA-tracrRNA hybridization complex directs Cas9 transferase to the invading DNA target, which acts as a protospacer, leading to the formation of a double-stranded break and the eventual cleavage of the foreign DNA. It is believed that this immune response can destroy the genetic material of the invader and stop the infection through the cleavage of the foreign DNA.
Fig.2 The naturally occurring CRISPR–Cas bacterial immunity. (Hashemi, 2020)
CD BioGlyco provides comprehensive, multiple types of glycoengineered cell constructs. Each of our protocols is quality tested for stability and flexibility to ensure client satisfaction. We hope to be your right-hand man in the field of glycobiology. Please feel free to contact us for more information.
References
About Us
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.